Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, X-Linked

Explore clinical trials studying Genetic Diseases, X-Linked. Study availability and eligibility vary by location and protocol.

1,244 public trials 227 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, X-Linked trial results

Completed

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

NCT00414583

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +21 more
Locations
  • Universitätsklinikum für Neurologie Graz, Austria
  • Department of Neurology, Universitaetsklinik fuer Neurologie Innsbruck Innsbruck, Austria
  • Wagner-Jauregg Linz, Department of Neurology Linz, Austria
  • Christian-Doppler-Klinik, Department für medizin. Studien Salzburg, Austria
View all 45 locations
View Trial Details
Completed

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease

NCT01268241

Conditions
Anderson-Fabry Disease, Brain Diseases, Brain Diseases, Metabolic, +21 more
Locations
  • Juan Fernandez Hospital, Department of Neurology Buenos Aires, Argentina
  • Unidad Renal Corrientes SRL, Medicina Interna Nefrólogo Corrientes, Argentina
  • UZA - University Ziekenhuis Antwerpen) Edegem, Belgium
  • University Hospital "Sestre Milosrdnice" Department of neuroimmunology and neurogenetic Zagreb, Croatia
View Trial Details
Completed

Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B

NCT00768287

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • City of Hope Duarte, California, United States
  • The Hemophilia Treatment Center of Orthopaedic Hospital Los Angeles, California, United States
  • Emory University School of Medicine Pediatric Hematology Atlanta, Georgia, United States
  • Rush University Medical Center-Pediatric Hematology Oncology Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease

NCT02489344

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Investigational Site Number 840002 Atlanta, Georgia, United States
  • Investigational Site Number 840003 Cincinnati, Ohio, United States
  • Investigational Site Number 840001 Fairfax, Virginia, United States
  • Investigational Site Number 250001 Garches, France
View Trial Details
Completed

Home Therapy With Replagal in Fabry Disease

NCT01355146

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Landeskrankenhaus Bregenz Bregenz, Austria
  • LKH-Universitätsklinikum Graz Graz, Austria
  • Paracelsus Medizinische Privatuniversität Salzburg Salzburg, Austria
  • Universitätsklinik für Innere Medizin III Vienna, Austria
View all 22 locations
View Trial Details
Completed

Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

NCT01822184

Conditions
Carbohydrate Metabolism, Inborn Errors, Cognition Disorders, Cognitive Dysfunction, +25 more
Locations
  • Childrens Hospital & Research Center Oakland Oakland, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina Division of Genetics and Metabolism Chapel Hill, North Carolina, United States
  • Hospital Universitario Austral Pilar, Buenos Aires, Argentina
View Trial Details
Completed

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

NCT02190149

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • Rady Childrens Hospital San Diego, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
View all 17 locations
View Trial Details

Related conditions